HealthBeacon PLC HealthBeacon - HBCN - Senior Appointment and Green Labs USA introduction

Healthbeacon

16/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220616:nRSP0579Pa&default-theme=true

RNS Number : 0579P  HealthBeacon PLC  16 June 2022

HealthBeacon announces appointment of VP of Global Operations and introduction
of Green Labs facility in the United States

Dublin, 16 June 2022: HealthBeacon plc, the leading digital therapeutics
company that develops products for managing injectable medications for
patients in the home, is pleased to announce the appointment of Omar Sosa as
Vice President of Global Operations and Green Labs USA.

With 15 years' pharmacy experience and a strong track record in delivering
growth, Omar brings a wealth of specialist expertise to HealthBeacon. He has
previously held senior roles at Priority Health Care, Aetna Specialty,
Oncology Therapeutics Network, Shoppers Drug Mart.

Omar founded Mevesi Inc, a business intelligence and data warehousing company
serving the pharmacy industry and served as CEO until it was acquired in 2018.
Following its acquisition, Omar worked as a consultant across various
healthcare organisations and served as the Chief Technology Officer of
Independent Medical Group, a multi-site infectious disease clinic.

In his new role, Omar will oversee HealthBeacon's business operations and as
it scales to 100,000 deployed devices by the end of 2023. In addition, Omar
will drive the growth of Green Labs facilities, customer care teams, and
production and distribution in six countries.

HealthBeacon will introduce its USA Green Labs facility in the United States
in Q4 2022. Having launched its first facility in Ireland in partnership with
Novartis earlier this year, HealthBeacon Green Labs is a positive step towards
addressing the global challenge of sustainably managing patients' waste and
supporting pharmaceutical companies to engage in more sustainable waste
management practices.

HealthBeacon's smart technology reminds the patient to take their medication
and notifies them when their sharps bin is nearing capacity. The full sharps
bin is then collected from the patient's home, undergoes a validated washing
regime and can then be returned to the patient for re-use, ensuring an
environmentally friendly service for patients.

Commenting on the appointment, HealthBeacon CEO, Jim Joyce, said: "This is an
important appointment for HealthBeacon and we are delighted to have someone of
Omar's calibre on board. Omar will support HealthBeacon's growth plans to
bring our proven injection adherence technology to millions of US customers
taking critical medications through injection in their homes. As we continue
to grow, we are mindful of the impact we want to have as a business on the
environment. Ultimately, we want to improve injection adherence in a
sustainable way and the introduction of our Green Labs facility in the United
States is a key step in doing that."

Omar Sosa commented on his appointment: "I am really excited to begin this
role with a company as exciting as HealthBeacon. The organisation has a clear
goal in aiming to improve patients' injection adherence globally and I am
looking forward to playing a role in that mission. The introduction of the
Green Labs facility in Florida later this year also means that we are going to
be doing this in a sustainable way in the United States."

For further information, contact:

 Enquiries:

 HealthBeacon:                                    Company.Secretary@HealthBeacon.com

 Laurence Flavin

 Goodbody (Euronext Listing Sponsor and Broker):  +353 (1) 667 0420

 David Kearney
 Stephen Kane

 Drury (Public Relations):
 Billy Murphy                                     +353 (0) 87 231 3085
 Cathal Barry                                     +353 (0) 87 227 9281

 

About HealthBeacon

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company that develops
products for managing injectable medications for patients in the home. The
HealthBeacon Injection Care Management System tracks adherence and persistence
with medication
schedules through the provision of medication management reminders, safe and sustainable
sharps disposal devices, educational tools, and artificial intelligence (AI) driven data analytics.
The Company operates across Europe, North America and the United
Kingdom and employs more than 70 people and has obtained more than 30 design
and utility patents. Peer reviewed evidence supports a 19% improvement in
therapy persistence by patients and up to 26% improvement in adherence to
therapy, which improves clinical outcomes and significantly improves
efficiency in health systems. The Company’s mission is to become the
world’s leading digital therapeutics platform for injectable medications.

Ends

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEBCGDLLUBDGDU